Page last updated: 2024-11-06

mitomycin and Epidermodysplasia Verruciformis

mitomycin has been researched along with Epidermodysplasia Verruciformis in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Epidermodysplasia Verruciformis: An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.

Research Excerpts

ExcerptRelevanceReference
"At 4 years of follow-up, no recurrence has been noted."1.42Bilateral recurrent ocular surface squamous cell cancer associated with epidermodysplasia verruciformis. ( Arora, T; Sharma, N; Sharma, S; Titiyal, JS, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arora, T1
Sharma, S1
Sharma, N1
Titiyal, JS1

Other Studies

1 other study available for mitomycin and Epidermodysplasia Verruciformis

ArticleYear
Bilateral recurrent ocular surface squamous cell cancer associated with epidermodysplasia verruciformis.
    BMJ case reports, 2015, Jan-30, Volume: 2015

    Topics: Adolescent; Amnion; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Cryosurgery; Epidermodysp

2015